Mercer Global Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.19M Buy
13,662
+4,276
+46% +$2.4M 0.01% 707
2026
Q1
$5.27M Buy
9,386
+2,040
+28% +$1.31M 0.01% 736
2025
Q4
$4.97M Buy
7,346
+759
+12% +$517K 0.01% 722
2025
Q3
$4.21M Buy
6,587
+1,690
+35% +$1.03M 0.01% 739
2025
Q2
$2.63M Sell
4,897
-191
-4% -$91.3K 0.01% 776
2025
Q1
$2.14M Buy
5,088
+421
+9% +$183K ﹤0.01% 818
2024
Q4
$1.93M Buy
4,667
+321
+7% +$141K ﹤0.01% 840
2024
Q3
$2.15M Buy
4,346
+51
+1% +$24.8K 0.01% 763
2024
Q2
$2.04M Buy
4,295
+176
+4% +$88.4K 0.01% 718
2024
Q1
$2.23M Buy
4,119
+422
+11% +$231K 0.01% 696
2023
Q4
$2.05M Sell
3,697
-572
-13% -$269K 0.01% 736
2023
Q3
$1.87M Sell
4,269
-1,005
-19% -$501K 0.01% 732
2023
Q2
$2.65M Buy
5,274
+181
+4% +$86.7K 0.01% 643
2023
Q1
$2.55M Buy
5,093
+331
+7% +$158K 0.01% 618
2022
Q4
$1.94M Buy
4,762
+2,912
+157% +$1.13M 0.01% 692
2022
Q3
$603K Buy
1,850
+106
+6% +$38.9K ﹤0.01% 1049
2022
Q2
$611K Buy
1,744
+197
+13% +$80.3K ﹤0.01% 1053
2022
Q1
$846K Sell
1,547
-176
-10% -$92.6K 0.01% 962
2021
Q4
$1.14M Buy
1,723
+359
+26% +$225K 0.01% 826
2021
Q3
$848K Sell
1,364
-16
-1% -$10.8K 0.01% 937
2021
Q2
$872K Buy
1,380
+329
+31% +$182K 0.01% 905
2021
Q1
$514K Buy
1,051
+40
+4% +$20K ﹤0.01% 1068
2020
Q4
$505K Buy
1,011
+229
+29% +$102K 0.01% 854
2020
Q3
$307K Sell
782
-14
-2% -$5.18K ﹤0.01% 954
2020
Q2
$263K Sell
796
-374
-32% -$108K ﹤0.01% 895
2020
Q1
$283K Buy
1,170
+369
+46% +$96.3K 0.01% 830
2019
Q4
$209K Sell
801
-56
-7% -$14.8K ﹤0.01% 1069
2019
Q3
$233K Buy
857
+81
+10% +$22.5K 0.01% 986
2019
Q2
$214K Buy
+776
New +$191K 0.01% 1028

Other funds holding IDXX

Mercer Global Advisors's IDXX Position: Q2 2026 in Review

Mercer Global Advisors increased its Idexx Laboratories (IDXX) stake by 46% in Q2 2026, buying an estimated $2.4M and bringing the position to 13,662 shares worth $7.19M. The position accounts for 0.01% of the portfolio, ranked #707.

Mercer Global Advisors first reported a position in IDXX in Q2 2019 and has held it in 29 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Mercer Global Advisors held 13,662 shares of Idexx Laboratories worth $7.19M as of Q2 2026.
  • Mercer Global Advisors bought 4,276 Idexx Laboratories shares in Q2 2026, an estimated $2.4M.
  • Idexx Laboratories made up 0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #707 holding.
  • Mercer Global Advisors first reported a position in Idexx Laboratories in Q2 2019 and has held it in 29 quarters since.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.